The metabolic syndrome is a multiplex risk factor for atherosclerotic cardiovascular disease
and type 2 diabetes. It is composed of atherogenic dyslipidemia, elevated blood pressure …

Background: Metabolic syndrome (MetS) is characterized by the simultaneous presence of
obesity, hypertension, dyslipidemia and hyperglycemia in an individual, leading to …

For many years, it has been recognized that hypertension tends to cluster with various
anthropometric and metabolic abnormalities including abdominal obesity, elevated …

Metabolic syndrome is a disorder based on insulin resistance. Metabolic syndrome is
diagnosed by a co-occurrence of three out of five of the following medical conditions …

The diagnosis of metabolic syndrome is based on the presence of central (abdominal)
obesity, increased blood pressure, elevated glucose and triglycerides, and low high-density …

The metabolic syndrome is a multiple risk factor complex for atherosclerotic cardiovascular
disease (ASCVD). These risk factors consist of atherogenic dyslipidemia, elevated blood …

Metabolic syndrome (MetS) is the constellation of metabolic risk factors that might foster
development of type 2 diabetes and cardiovascular disease. Abdominal obesity and insulin …

Several recent clinical trials show that blocking agents of the renin-angiotensin-aldosterone
system (RAAS) reduce cardiovascular events in patients with metabolic syndrome based on …

Abstract Angiotensin II (Ang II)-induced injury of vascular smooth muscle cells (VSMCs)
serves an important role in hypertension and other cardiovascular disorders. Transient …

Sildenafil, a phosphodiesterase-5 inhibitor sold as Viagra, is a cardioprotector against
myocardial ischemia/reperfusion (I/R) injury. Our study explored whether sildenafil protects …